Accueil » Communiqués de presse » Valbiotis is patented for its active substance TOTUM•63 in China, a large potential market for the prevention of type 2 diabetes and metabolic diseases (IN FRENCH).
Les communiqués de presse
19May2021
Valbiotis is patented for its active substance TOTUM•63 in China, a large potential market for the prevention of type 2 diabetes and metabolic diseases (IN FRENCH).
